WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition.

In a five-year study of binge eating disorder, most of the study participants still met the criteria for the disorder at the five-year mark, although some had made improvements. Photo by Adobe ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers. Lisdexamfetamine, marketed as Vyvanse, first ...

Add Yahoo as a preferred source to see more of our stories on Google. (Diana Ramirez/De Los) Food always powered Anahi Araiza through study sessions and cultural gatherings. But after putting on some ...

Binge eating disorder may not be what doctors thought it was. At least when it comes to relapsing. A study published today in the journal Psychological Medicine by scientists from McLean Hospital, a ...

Effective treatments are available for binge eating disorder (BED), conclude the authors of a new systematic literature review and meta-analysis. Therapist-led cognitive-behavioral therapy (CBT), the ...

Binge eating disorder is the most common type of eating disorder in the U.S. Binge eating is characterized as eating large amounts of food in a short period, typically under two hours. People with ...

This is read by an automated voice. Please report any issues or inconsistencies here. Food always powered Anahi Araiza through study sessions and cultural gatherings. But after putting on some weight ...